BILL · Insider Trading
BILL Holdings, Inc.
Every open-market purchase and sale reported by BILL officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-20 | Lee Kirkpatrick | Director | M | +2,611 | — |
| 2026-10-20 | Peter A Feld | Director | M | +2,611 | — |
| 2026-09-17 | Rene A. Lacerte | CEO | A | +116,619 deriv. | — |
| 2026-09-17 | Michael Cieri | Chief Product Officer | A | +46,856 deriv. | — |
| 2026-09-17 | Rohini Jain | Chief Financial Officer | A | +67,681 deriv. | — |
| 2026-09-04 | Rene A. Lacerte | CEO | Sell | −257,243 | −$12.53M |
| 2026-09-01 | Rene A. Lacerte | CEO | MIXED | +24,024 | −$1.25M |
| 2026-09-01 | Michael Cieri | Chief Product Officer | MIXED | — | −$964.77K |
| 2026-09-01 | Rohini Jain | Chief Financial Officer | MIXED | — | −$3.04M |
| 2026-08-19 | Rene A. Lacerte | CEO | A | +52,893 deriv. | — |
| 2026-08-19 | Michael Cieri | Chief Product Officer | A | +19,590 deriv. | — |
| 2026-08-19 | Rohini Jain | Chief Financial Officer | A | +35,262 deriv. | — |
| 2026-06-01 | Mary Kay Bowman | See Remarks | MIXED | +11,958 | −$243.11K |
| 2026-06-01 | Kenneth A Moss | Chief Technology Officer | MIXED | +12,637 | −$454.13K |
| 2026-06-01 | Rene A. Lacerte | CEO | MIXED | +15,364 | −$554.88K |
| 2026-06-01 | Michael Cieri | Chief Product Officer | MIXED | — | −$1.86M |
| 2026-03-03 | Kenneth A Moss | Chief Technology Officer | MIXED | +15,895 | −$431.82K |
| 2026-03-03 | Mary Kay Bowman | See Remarks | MIXED | +13,872 | −$223.73K |
| 2026-03-03 | John R. Rettig | COO | MIXED | +15,945 | −$436.16K |
| 2026-03-03 | Rene A. Lacerte | CEO | MIXED | +18,639 | −$558.96K |
| 2026-01-20 | Keri Gohman | Director | M | +1,531 | — |
| 2026-01-20 | Daniel A Wernikoff | Director | M | +1,531 | — |
| 2025-12-15 | Elizabeth S. Johnson | Director | A | +7,278 deriv. | — |
| 2025-12-15 | Natalie Marie Derse | Director | A | +7,278 deriv. | — |
| 2025-12-15 | David Hornik | Director | A | +3,639 deriv. | — |
| 2025-12-15 | Daniel A Wernikoff | Director | A | +3,639 deriv. | — |
| 2025-12-15 | Alison Wagonfeld | Director | A | +3,639 deriv. | — |
| 2025-12-15 | Tina Reich | Director | A | +3,639 deriv. | — |
| 2025-12-15 | Allison Mnookin | Director | A | +3,639 deriv. | — |
| 2025-12-15 | Keri Gohman | Director | A | +3,639 deriv. | — |
| 2025-12-15 | Aida Alvarez | Director | A | +3,639 deriv. | — |
| 2025-12-15 | Katherine M. A. Kline | Director | A | +3,639 deriv. | — |
| 2025-12-09 | Rene A. Lacerte | CEO | G | −15,190 | — |
| 2025-12-09 | Steven Cakebread | Director | M | +2,095 | — |
| 2025-12-09 | Aida Alvarez | Director | M | +2,095 | — |
| 2025-12-09 | Katherine M. A. Kline | Director | M | +2,095 | — |
| 2025-12-09 | Allison Mnookin | Director | M | +2,095 | — |
| 2025-12-09 | David Hornik | Director | M | +2,095 | — |
| 2025-12-09 | Brian Jacobs | Director | M | +2,095 | — |
| 2025-12-09 | Alison Wagonfeld | Director | M | +2,095 | — |
| 2025-12-09 | Tina Reich | Director | M | +2,095 | — |
| 2025-12-05 | John R. Rettig | COO | G | −10,500 | — |
| 2025-12-03 | Germaine Cota | SVP, FINANCE & ACCOUNTING | Sell | −1,104 | −$56.56K |
| 2025-12-02 | John R. Rettig | COO | MIXED | +13,781 | −$713.18K |
| 2025-12-02 | Germaine Cota | SVP, FINANCE & ACCOUNTING | MIXED | +1,831 | −$95.03K |
| 2025-12-02 | Mary Kay Bowman | See Remarks | MIXED | +11,282 | −$383.75K |
| 2025-12-02 | Rene A. Lacerte | CEO | MIXED | +15,396 | −$796.83K |
| 2025-12-02 | Kenneth A Moss | Chief Technology Officer | MIXED | +12,679 | −$651.35K |
| 2025-10-23 | Alison Wagonfeld | Director | M | +1,039 | — |
| 2025-10-21 | Lee Kirkpatrick | Director | A | +7,831 deriv. | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Peter A Feld | Director | 7,028,359 | $349.87M |
| Rene A. Lacerte | CEO | 264,024 | $13.14M |
| Brian Jacobs | Director | 229,502 | $11.42M |
| John R. Rettig | COO | 222,370 | $11.07M |
| Kenneth A Moss | Chief Technology Officer | 177,182 | $8.82M |
| Mary Kay Bowman | See Remarks | 74,734 | $3.72M |
| David Hornik | Director | 43,696 | $2.18M |
| Peter J Kight | Director | 34,081 | $1.70M |
| Rohini Jain | Chief Financial Officer | 33,470 | $1.67M |
| Scott Wagner | Director | 14,714 | $732.46K |
| Michael Cieri | Chief Product Officer | 11,751 | $584.96K |
| Rajesh A. Aji | CLO & CCO | 11,477 | $571.33K |
| Katherine M. A. Kline | Director | 11,027 | $548.92K |
| Germaine Cota | SVP, FINANCE & ACCOUNTING | 10,812 | $538.22K |
| Aida Alvarez | Director | 10,207 | $508.10K |
| Tina Reich | Director | 9,482 | $472.01K |
| Allison Mnookin | Director | 8,537 | $424.97K |
| Steven Cakebread | Director | 8,537 | $424.97K |
| Stephen Fisher | Director | 7,396 | $368.17K |
| Alison Wagonfeld | Director | 3,134 | $156.01K |
| Lee Kirkpatrick | Director | 2,611 | $129.98K |
| Daniel A Wernikoff | Director | 1,531 | $76.21K |
| Keri Gohman | Director | 1,531 | $76.21K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the BILL quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.